Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Letrozole approved in Canada

Sep. 10, 1997

Heat treatment for liver cancer assessed in clinical trials

Sep. 10, 1997

Another Isis oligonucleotide enters clinical testing

Sep. 10, 1997

Bexxar now administered on outpatient basis

Sep. 10, 1997

GSH prevents cisplatin-induced toxicity

Sep. 9, 1997

Treatment for preleukemic disorder from Milkhaus enters phase III

Sep. 9, 1997

GeneMedicine begins phase I testing of IL-2 Cancer Gene Medicine

Sep. 8, 1997

Novel integrin receptor antagonists from DuPont Merck

Sep. 8, 1997

Antimitotic cryptophycin compounds

Sep. 5, 1997

Vitamin D derivatives as progesterone antagonists

Sep. 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...